# High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease

> **NCT00247143** · NA · UNKNOWN · sponsor: **Lampiris, Harry W., M.D.** · enrollment: 20 (—)

## Conditions studied

- HIV
- AIDS

## Interventions

- **DRUG:** Kaletra (drug)

## Key facts

- **NCT ID:** NCT00247143
- **Lead sponsor:** Lampiris, Harry W., M.D.
- **Sponsor class:** INDIV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (—)
- **Last updated:** 2006-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00247143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00247143, "High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00247143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*